Form 4 for SER Serina Therapeutics, Inc.

Accepted 2024-05-23 00:00:00 ET · period of report 2024-05-17 · accession 0001493152-24-021176 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
MI	2024-05-23	2024-05-17+	SER	MINTZ STEVEN	Dir	P - Purchase	$9.76	+12.4K	1,240	New	+$120.8K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2024-05-20	P	A	1,240	$9.44	1,240	I By Adult Child 1	—	—	(F1) The Reporting Person may be deemed to share voting, investment and dispositive power with respect to these securities. The Reporting Person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose.
2	Common	Common Stock	2024-05-21	P	A	2,500	$9.75	9,900	I By Spouse	—	—
3	Common	Common Stock	2024-05-21	P	A	6,651	$10.00	7,400	I By Spouse	—	—
4	Common	Common Stock	2024-05-20	P	A	195	$9.48	749	I By Spouse	—	—
5	Common	Common Stock	2024-05-17	P	A	554	$8.50	554	I By Spouse	—	—
6	Common	Common Stock	2024-05-20	P	A	1,240	$9.42	1,240	I By Adult Child 2	—	—	(F2) The Reporting Person may be deemed to share voting, investment and dispositive power with respect to these securities. The Reporting Person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose.